Retatrutide for Men

Men are often underrepresented in weight loss discussions, but obesity affects men's health profoundly -- and in some ways differently from women. Male obesity is characterized by preferential visceral fat accumulation (the "beer belly"), which is the most metabolically dangerous fat depot. This visceral fat drives insulin resistance, cardiovascular disease, and suppresses testosterone production, leading to reduced muscle mass, fatigue, low libido, and erectile dysfunction. Retatrutide's Phase 2 trial data showing 24% average weight loss offers men a powerful tool to address these interconnected health challenges.

Visceral Fat: Men's Biggest Health Threat

Men tend to accumulate fat around the organs (visceral fat) rather than under the skin (subcutaneous fat). This android fat distribution pattern is far more dangerous because visceral fat produces inflammatory cytokines that accelerate atherosclerosis, releases free fatty acids into the portal circulation that drive liver fat accumulation and insulin resistance, and compresses abdominal organs including the kidneys (raising blood pressure). Retatrutide's glucagon receptor activation specifically targets visceral and hepatic fat, making it particularly well-suited for addressing men's primary fat depot.

Weight Loss and Testosterone Recovery

One of the most important benefits of weight loss for men is testosterone recovery. Obesity suppresses testosterone through multiple mechanisms: aromatase enzyme in fat tissue converts testosterone to estrogen, and excess estrogen suppresses the hypothalamic-pituitary-gonadal axis, reducing testosterone production. Weight loss reverses this process. Studies show that significant weight loss can increase total testosterone by 50-100+ ng/dL, with some men moving from clinically low levels to normal range. This testosterone recovery improves energy, muscle mass, libido, mood, and further supports weight maintenance in a positive cycle.

Muscle Preservation for Men

Men typically have higher baseline lean mass and are often more concerned about muscle loss during weight loss. Muscle preservation is critical and achievable with proper approach. Resistance training at least 3 times weekly, protein intake of 1.2-1.6 g/kg/day, and adequate sleep support lean mass retention during weight loss. Retatrutide's glucagon component may offer a slight advantage here by preferentially promoting fat oxidation over muscle catabolism.

Cardiovascular Risk Reduction

Men face higher cardiovascular mortality than women, and obesity dramatically amplifies this risk. The cardiovascular benefits of retatrutide-level weight loss include blood pressure reduction, lipid improvement, reduced inflammation, and improved endothelial function. Semaglutide's SELECT trial demonstrated a 20% reduction in major cardiovascular events, and retatrutide's greater weight loss could yield even larger benefits.

Take Action on Your Health

Men often delay seeking weight loss treatment. Compounded semaglutide ($99/mo) and compounded tirzepatide ($125/mo) are available today and can begin improving cardiovascular health, testosterone levels, and quality of life immediately.